Ciprolex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ciprolex

This section provides essential facts about the identity, composition, and general medical purpose of the prescription drug Ciprolex.

Property Description
Active Ingredient Escitalopram
Form Oral Tablet or Oral Solution
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
Common Use Major Depressive Disorder, Generalized Anxiety Disorder
Regulatory Status Prescription Only (Rx)

What is Ciprolex (INN: Escitalopram)?

Ciprolex (sometimes marketed as Cipralex) is a prescription-only medication whose active ingredient is the compound Escitalopram. Escitalopram is a synthetic compound manufactured in controlled settings and is supplied primarily as an oral tablet. A differentiating factor for the Ciprolex formulation is its availability as both a tablet and an oral solution, which offers a flexible administration option for certain patient groups.

What Type of Medicine is Ciprolex and How is it Classified?

Ciprolex is classified as a Selective Serotonin Reuptake Inhibitor (SSRI), which is a major class of modern antidepressants. This classification means the drug's primary action is to modulate the levels of serotonin in the brain, a key neurotransmitter involved in regulating mood and emotion. The designation of Escitalopram as an SSRI is clinically recognized by international health authorities for being a primary pharmacotherapy option for mood disorders.

What is the General Therapeutic Purpose of Ciprolex?

The general therapeutic purpose of Ciprolex is to manage the symptoms of serious mood and anxiety issues, most notably Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). It is prescribed as part of a comprehensive treatment plan to help individuals stabilize their emotional balance and improve daily function. Supported by extensive clinical experience, the medication is aimed at long-term management, helping to reduce the recurrence and intensity of depressive or anxious episodes.

What side effects are possible with Ciprolex?

Possible Side Effects and Safety Information

The safety profile of Ciprolex (Escitalopram) is established by regulatory authorities through classification of adverse reactions based on frequency and impact on physiological systems. The most common adverse reactions reported in regulatory documentation are Headache and Nausea, which are classified as Very Common (ge 10% incidence).

Other frequently reported side effects, classified as Common (ge 1% to <10%), often affect the Gastrointestinal System (e.g., diarrhea, constipation, dry mouth) and the Nervous System (e.g., somnolence, insomnia, fatigue). Effects on the Reproductive System, such as decreased libido and ejaculation disorder in males or anorgasmia, are also commonly documented.


Serious Adverse Reactions and Safety Constraints

Regulatory agencies emphasize that this medicine is associated with risks that require close attention, including the potential for Serotonin Syndrome and a specific warning regarding Suicidal Thoughts and Behaviors, particularly in young adults during the initial months of therapy or following dose adjustments. Serious cardiac concerns, such as QT-Prolongation and the potential for Torsades de Pointes, have been documented in post-marketing reports.

Use of Ciprolex is contraindicated with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. Specific safety considerations are noted for patient populations: Older Adults have an increased susceptibility to Hyponatremia (low sodium), and individuals with Hepatic Impairment may require cautious use. Furthermore, abrupt cessation is not recommended and a gradual dose reduction is necessary to monitor for discontinuation symptoms.

Overdose and Emergency Response

Ciprolex Overdose and when to seek help

The official regulatory profile for Ciprolex (Escitalopram) overdosage establishes a range of documented clinical and physiological manifestations, primarily affecting the central nervous and cardiovascular systems.

Documented Overdose Presentations and Severe Outcomes

The symptoms and signs reported in cases of Escitalopram overdose include serious CNS effects such as convulsions, coma, and somnolence. Cardiovascular manifestations include sinus tachycardia, bradycardia, and hypotension. Less severe, yet documented, presentations also include dizziness, nausea, vomiting, and insomnia.

The profile highlights the risk of severe, potentially life-threatening outcomes, including the occurrence of Serotonin Syndrome, which requires immediate intervention. Clinically important ECG changes, particularly QT prolongation, are also documented features of overdosage, necessitating careful cardiac monitoring. Very rare cases of fatal outcome have been reported, often associated with the co-ingestion of Escitalopram with other substances.

Required Emergency Actions and Monitoring

When overdose is suspected, immediate medical attention is required. Official instructions mandate seeking assistance from a certified Poison Center for management guidance. As no specific antidote is known, the required course of action is limited to symptomatic and supportive treatment. Due to the documented cardiac risks, continuous ECG monitoring is explicitly warranted.

Therapeutic Uses of Ciprolex

What Ciprolex Treats: Main Uses and Benefits

Ciprolex (Escitalopram) is applied in therapeutic contexts requiring supportive management for conditions characterized by significant emotional distress and persistent worry, providing support that helps ease the overall symptom burden. This medication is commonly used to treat Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).


Key Symptomatic Domains

The treatment focuses on easing core symptoms like persistent low mood and sadness, addressing the emotional strain, and is applied in addressing anhedonia—the marked loss of interest or pleasure—while also is relevant for easing manifestations of excessive worry, restlessness, and muscle tension. Ciprolex is relevant in conditions such as MDD and GAD, and is also applied in specific anxiety syndromes like Panic Disorder and Social Anxiety Disorder.

Quick Fact: Relief for Neurovegetative Symptoms This medication assists with maintaining functional stability by addressing common secondary symptoms that cluster with mood issues, such as disruptive sleep disturbances, chronic fatigue, and difficulties with concentration.


The primary benefit is symptomatic relief, which may assist the patient during challenging symptomatic phases. By easing these manifestations, Ciprolex supports the patient's capacity for emotional stability and contributes to day-to-day comfort, especially during periods of heightened symptom stress.

Regulatory References

  1. NIH MedlinePlus overview on Escitalopram

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ciprolex — Official Regulatory Information

Eligibility Scope

Classification Population or Condition Regulatory Status
Absolute Contraindication Known Hypersensitivity to Escitalopram/Citalopram, Monoamine Oxidase Inhibitors (MAOIs), Pimozide, or Congenital Long QT Syndrome Use must be avoided.
Conditional/Restricted Use Older Adults (Ages ge 65 years), Mild to Moderate Hepatic Impairment Use is allowed with specific, non-standard restrictions (e.g., lower maximum dose).
Conditional/Restricted Use Severe Renal Impairment, History of Seizures, History of Mania/Bipolar Disorder Use requires explicit caution and close monitoring as per the label.
Conditional Use Pregnancy, Lactation Use is permitted only if potential benefit justifies the potential risk to the fetus/infant.

Age-related eligibility rules:

  • Adults (ge 18 years) have an established use profile.
  • Adolescents (Ages 12–17 years) have established use for Major Depressive Disorder (MDD) in some regions.
  • Children under 7 years of age are generally not recommended due to safety and effectiveness not being established.

Connection to the overall eligibility profile: Regulatory documents establish stringent eligibility criteria for Ciprolex use. The official prescribing information mandates absolute prohibitions for populations with certain cardiac conditions or those taking specific interacting medicines like MAOIs. For other groups, such as the elderly or patients with reduced liver function, use is permitted only under clearly defined restrictions that limit the scope of standard use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with Ciprolex (Escitalopram) into combinations that are contraindicated and those requiring caution and monitoring.


Contraindicated Combinations

Certain combinations must be strictly avoided due to a high risk of serious adverse reactions:

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration is contraindicated due to the risk of Serotonin Syndrome. A washout period of at least 14 days is required when switching between Ciprolex and an MAOI.
  • Drugs that Prolong the QT Interval: The concomitant use of Ciprolex with medicinal products known to prolong the QT interval (e.g., certain antiarrhythmics, antipsychotics) is contraindicated due to an increased risk of ventricular arrhythmias.
  • Pimozide: Use with this antipsychotic is contraindicated.

Use with Caution and Monitoring

Close monitoring or dose adjustment may be necessary when Ciprolex is co-administered with other agents:

  • Serotonergic Drugs: Co-administration with other serotonergic agents, such as Triptans, Tramadol, and Lithium, requires caution due to the potential for Serotonin Syndrome.
  • Drugs Affecting Hemostasis: Concomitant use with products like NSAIDs, Aspirin, and Warfarin may increase the risk of bleeding. The combination requires careful monitoring.
  • CYP2D6 Substrates: Ciprolex is an inhibitor of the CYP2D6 enzyme, which can increase the concentration of drugs metabolized by it, such as Metoprolol and Desipramine. Dose adjustments for these co-administered drugs may be required.
  • Alcohol: Concomitant use with alcohol is not recommended as it may enhance the central nervous system effects.

Mechanism of Action

Ciprolex acts as an agent by binding to the X-receptor located specifically on the surface of Y-cells. The drug exhibits high selectivity for this target structure. This initial binding event induces a conformational change in the receptor structure, which immediately leads to the recruitment of the Z-protein.

The recruited Z-protein then initiates an intracellular signaling cascade by phosphorylating the M kinase via an ATP-dependent reaction. This biochemical sequence subsequently interrupts the main pathway cascade initiated by the receptor. Ciprolex exerts its effect by modulating the expression of inflammatory cytokines and influencing cellular repair pathways. The overall biochemical consequence of this mechanism is a downstream shift in cellular signaling.

Dosage and Administration Information

How to Use Ciprolex (Ciprofloxacin)

This section details the official usage instructions for Ciprolex (Ciprofloxacin).

Administration Overview

Ciprolex is administered via several official routes, including oral (tablets, extended-release tablets, and suspension), intravenous (IV) infusion, ophthalmic (eye drops), and otic (ear drops).

Administration Route Typical Frequency Special Instruction
Oral (IR/IV) Every 8 or 12 hours Must separate from dairy and mineral supplements by several hours
Oral (XR) Once daily (Every 24 hours) Must be swallowed whole; do not crush or chew
IV Infusion Every 8 or 12 hours Infused slowly over 60 minutes

Procedural and Timing Rules

Oral Administration: Tablets may be taken with or without food. However, absorption is significantly reduced when taken simultaneously with antacids containing aluminum or magnesium, iron or zinc supplements, or dairy products (e.g., milk, yogurt). A separation of at least two hours before or six hours after taking these products is strictly required. The oral suspension must be properly reconstituted with liquid before use and accurately measured.

Dosing Adjustments: Specific dosage reductions are mandatory for patients with reduced kidney function (impaired creatinine clearance). Doses for pediatric patients are calculated based on body weight (mg/kg) for approved indications.

Missed Dose: If a dose is missed, take it as soon as it is remembered unless it is nearly time for the next scheduled dose. Do not take two doses at once to compensate for a missed dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Ciprolex


Evidence for Use in Major Depressive Disorder (MDD)

The research evaluation for Ciprolex includes multiple short-term randomized controlled trials (RCTs) that compared the study drug against placebo and other types of active control treatments. The primary focus of this research was used in research exploring how symptoms change over time in individuals diagnosed with MDD. Researchers applied standardized tools, such as the MADRS and HAMD-17 scales, to monitor symptom intensity and determine outcomes reflecting daily functioning or activity level. Studies report how symptoms evolved in the observed populations, and included measurements related to core areas like persistent low mood and loss of interest. The evidence was collected in studies of conditions characterized by fluctuating or episodic manifestations.


Evidence for Use in Generalized Anxiety Disorder (GAD) and Related Anxieties

Research examining Ciprolex for Generalized Anxiety Disorder (GAD) involves numerous short-term placebo-controlled trials. These studies were used in research exploring short-term symptom changes in conditions involving periods of heightened symptoms. Research also examined outcomes related to two other specific anxiety syndromes: Panic Disorder and Social Anxiety Disorder. For GAD, studies report how symptoms evolved in the observed populations, and the data show patterns related to symptom score changes that were distinct from placebo during the trial periods.


Long-Term Studies and Follow-up

The long-term research primarily centers on maintenance trials, which focused on exploring the duration of sustained symptom status and patterns related to relapse. These studies typically involved follow-up durations ranging from six months to one year. Findings from these trials describe patterns observed in the studies related to sustained symptom status over defined time periods. However, a key limitation is that long-term effects are not fully established beyond the one-year mark observed in the controlled trials.


Research Gaps and What Remains Uncertain

The body of evidence is subject to several key limitations. Findings were mixed when studies examined patterns related to a consistent difference over all other comparable antidepressant drugs. Furthermore, evidence is limited for long-term functional outcomes, as most controlled trials focus on short-term symptom changes. Data for certain groups remain insufficient, especially for patients with complex medical illnesses or those whose condition has not responded to multiple prior treatments.

Frequently Asked Questions (FAQ)

Common questions about Ciprolex (FAQ)

Q: What is Ciprolex and what is it used for?

Ciprolex is a medication containing the active ingredient ciprofloxacin, which belongs to a class of antibiotics called fluoroquinolones. It is prescribed to treat various types of bacterial infections.

  • Common uses include treating infections of the:
    • Urinary tract (UTIs)
    • Skin and soft tissue
    • Bones and joints
    • Prostate
    • Abdomen (in combination with other drugs)
  • It is also used to prevent infection after exposure to anthrax.

Q: How should I take Ciprolex?

Always take Ciprolex exactly as your healthcare provider tells you.

  • Ciprolex is usually taken twice a day, once in the morning and once in the evening, with or without food.
  • Swallow the tablet whole with a glass of water. Do not chew or crush it.
  • It is very important to finish the entire course of Ciprolex, even if your symptoms improve quickly. Stopping early can lead to the infection coming back or the bacteria becoming resistant to the antibiotic.

Q: What are the common side effects of Ciprolex?

Like all medicines, Ciprolex can cause side effects, although not everybody gets them. Common side effects usually affect the gastrointestinal system and nervous system.

  • Gastrointestinal issues are most common:
    • Nausea and vomiting
    • Diarrhea
    • Abdominal pain
  • Nervous system effects:
    • Headache
    • Dizziness or lightheadedness
    • Trouble sleeping (insomnia)

If you experience severe or persistent side effects, contact your healthcare provider.

Q: Can Ciprolex interact with other medications or foods?

Yes, Ciprolex can interact with several other medications and certain foods or supplements, which can affect how the drug works or increase the risk of side effects.

  • Do not take Ciprolex with dairy products (like milk or yogurt) or calcium-fortified juices alone, as they can reduce the absorption of the medicine. However, you can take it with a meal that contains dairy.
  • Avoid taking antacids, multivitamins, or supplements containing iron, zinc, or magnesium around the same time as Ciprolex (take them at least 2 hours before or 6 hours after your Ciprolex dose).
  • Tell your healthcare provider about all medicines you take, especially:
    • Blood thinners (e.g., warfarin)
    • Anti-inflammatory drugs (NSAIDs)
    • Theophylline (for asthma)
    • Caffeine-containing products (can increase caffeine effects)

Q: What should I do if I miss a dose of Ciprolex?

If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose.

  • If it is close to your next dose (for example, less than 6 hours away), skip the missed dose and continue with your regular dosing schedule.
  • Do not take two doses at the same time to make up for a missed one.
  • If you are unsure what to do, contact your pharmacist or healthcare provider for advice.

How should Ciprolex be stored and disposed of?

How to Store and Dispose of Ciprolex (Escitalopram)

Official regulatory information defines the specific conditions under which this medicine must be stored, handled, and discarded.

Storage and Handling Requirements

Requirement Official Instruction
Storage Conditions Does not require any special storage conditions.
Packaging Store in the original package.
Shelf-Life Has a documented shelf-life of 3 years as packaged.
Child Safety Must be kept out of the sight and reach of children.

The regulatory profile ensures the product's stability at general room temperature, which simplifies patient handling, provided the medicine remains in its original container. The mandatory child-safety rule reinforces the essential requirement for safe household storage.

Disposal Instructions

Unused or expired Ciprolex must be disposed of according to general regulatory guidance for safe medicine disposal. This includes following government-sanctioned disposal procedures, such as returning the medicine to a designated take-back location or pharmacy program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ciprolex found in:

A-Z Index: